CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Early Translational III |
Direct reprogramming towards vascular progenitors for the treatment of ischemia |
$2,340,000 |
University of California, San Diego |
Dr. Eric D. Adler MD |
Early Translational III |
Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease |
$1,701,575 |
University of California, Davis |
Walter Douglas Boyd |
Early Translational III |
Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair |
$4,631,754 |
Stanford University |
Dr. Bertha Chen |
Early Translational III |
Autologous iPSC Therapy for Urinary Incontinence |
$4,715,738 |
University of California, San Diego |
Mark H Tuszynski |
Early Translational III |
Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury |
$4,600,447 |
University of California, Davis |
Prof. Kyriacos A. Athanasiou Ph.D |
Early Translational III |
Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells |
$1,735,703 |
University of California, Irvine |
Craig M. Walsh |
Early Translational III |
Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells |
$4,535,005 |
Scripps Research Institute |
Peter G. Schultz |
Early Translational III |
Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis |
$2,559,333 |
University of California, San Francisco |
Dr. Arnold Kriegstein |
Early Translational III |
Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury |
$1,623,251 |
University of California, San Diego |
Gene Wei-Ming Yeo |
Early Translational III |
Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons |
$1,532,323 |
University of California, Santa Cruz |
Dr. David Haussler |
Training Grant I-3 |
Training Program in Systems Biology of Stem Cells |
$1,133,701 |
University of California, Santa Barbara |
Dr. Dennis O. Clegg |
Training Grant I-3 |
UCSB Stem Cell Biology Training Program |
$975,334 |
Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Training Grant I-3 |
Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies |
$1,261,333 |
California Institute of Technology |
Paul H. Patterson |
Training Grant I-2 |
Training in Stem Cell Biology at CIT |
$1,817,214 |
Children’s Hospital of Los Angeles |
Dr. Donald B. Kohn |
Training Grant I-2 |
Training Grant 1 |
$2,173,872 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Mark Mercola |
Training Grant I-2 |
Burnham Institute CIRM Stem Cell Training Grant (Type II) |
$1,061,865 |
Gladstone Institutes, J. David |
Dr. Robert W Mahley |
Training Grant I-2 |
Gladstone CIRM Scholar Program |
$2,192,073 |
Scripps Research Institute |
Peter G. Schultz |
Training Grant I-2 |
Training Grant I |
$1,021,395 |
University of California, Davis |
Dr. Frederick J Meyers MD |
Training Grant I-1 |
Stem Cell Research Training Grant |
$1,780,859 |
University of California, San Francisco |
Dr. Susan J Fisher PhD |
Training Grant I-1 |
Training Grant I |
$2,868,145 |
University of California, Los Angeles |
Dr. Owen N Witte M.D. |
Training Grant I-1 |
CIRM Type I Comprehensive Training Program |
$3,660,398 |
University of Southern California |
Dr. Robert E Maxson |
Training Grant I-1 |
CIRM Stem Cell Biology Training Grant |
$2,332,431 |
University of California, Irvine |
Dr. Peter Bryant |
Training Grant I-1 |
Stem Cell Research Training Grant |
$1,935,487 |
University of California, Berkeley |
Randy W. Schekman |
Training Grant I-1 |
Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland |
$2,360,457 |
University of California, San Diego |
Dr. Lawrence S. B. Goldstein |
Training Grant I-1 |
Interdisciplinary Stem Cell Training Program at UCSD |
$3,459,396 |
Stanford University |
Michael T. Longaker M.D. |
Training Grant I-1 |
Stanford CIRM Training Program |
$3,035,282 |
University of California, Davis |
Dr Mehrdad Abedi |
Disease Team Therapy Planning I |
Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients |
$66,880 |
University of California, Davis |
Dr. John Laird |
Disease Team Therapy Planning I |
Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia |
$76,066 |
University of California, Davis |
Dr. Vicki Wheelock |
Disease Team Therapy Planning I |
MSC engineered to produce BDNF for the treatment of Huntington’s disease |
$97,564 |
Cedars-Sinai Medical Center |
Professor Clive Niels Svendsen |
Disease Team Therapy Planning I |
Stem Cells Secreting GDNF for the Treatment of ALS |
$63,487 |
Stanford University |
Dr. Albert J Wong |
Disease Team Therapy Planning I |
Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma |
$109,750 |
Stanford University |
Dr. Judith A Shizuru |
Disease Team Therapy Planning I |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$90,147 |
OncoMed Pharmaceuticals, Inc. |
Timothy Hoey |
Disease Team Therapy Planning I |
Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency |
$65,120 |
Cedars-Sinai Medical Center |
Dr. Dan Gazit |
Disease Team Therapy Planning I |
Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. |
$107,622 |
StemCells, Inc. |
Dr. Alexandra Capela |
Disease Team Therapy Planning I |
Neuroprotection to treat Alzheimer’s: a new paradigm using human central nervous system cells |
$90,101 |
University of California, Los Angeles |
Dr. Stanley Nelson |
Disease Team Therapy Planning I |
Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$68,947 |
Geron Corporation |
Dr. Jane Stephanie Lebkowski Dr. |
Disease Team Therapy Planning I |
Preclinical Development and First-In-Human Testing of GRNCM1 in Advanced Heart Failure |
$0 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Marcel Daadi Dr. |
Disease Team Therapy Planning I |
Neural Stem Cell-Based Therapy For Parkinson’s Disease |
$63,952 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Stuart A Lipton |
Disease Team Therapy Planning I |
hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease |
$96,448 |
University of California, Davis |
Nancy E. Lane |
Disease Team Therapy Planning I |
Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis |
$107,750 |
University of Southern California |
Roberta Diaz Brinton |
Disease Team Therapy Planning I |
A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer’s Disease |
$107,961 |
Samumed, LLC |
John Hood |
Disease Team Therapy Planning I |
Clinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures |
$99,110 |
Stanford University |
Dr. Robert Robbins |
Disease Team Therapy Planning I |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$73,030 |
University of California, Davis |
Dr. Martin Birchall |
Disease Team Therapy Planning I |
Airways for Children |
$19,800 |
University of California, Los Angeles |
Dr. Antoni Ribas MD/PhD |
Disease Team Therapy Planning I |
Genetic Re-programming of Stem Cells to Fight Cancer |
$97,785 |
California State University San Marcos Corporation |
Dr. Bianca Romina Mothé |
Bridges |
California State University-San Marcos CIRM Bridges to the Stem Cell Research Training Grant |
$4,114,712 |
Cal State Univ, Long Beach |
Dr. Lisa S Klig |
Bridges |
CIRM Stem Cell Research Biotechnology Training Program at CSULB |
$3,487,091 |
Cal Poly Pomona Foundation |
Dr. Jill Adler-Moore |
Bridges |
Cal Poly Pomona and Cal State LA Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education |
$3,056,191 |
San Francisco State University |
Dr. Carmen Domingo |
Bridges |
SFSU Bridges to Stem Cell Research |
$4,168,243 |
Humboldt State University Sponsored Programs Foundation |
Dr. Jacob Varkey |
Bridges |
The HSU CIRM Bridges to Stem Cell Research Certificate Program |
$3,195,858 |